A third Rituxan patient has developed a serious and often fatal brain infection called progressive multifocal leukoencephalopathy (PML). According to a statement posted on the Food Drug Administration (FDA) Web site, this is the first case of PML in a patient with rheumatoid arthritis treated with Rituxan who has not previously [...]